Latest SpectraCure News & Updates

See the latest news and media coverage for SpectraCure. We track all announcements, press releases, and industry mentions in real time, all in one place.

SpectraCure

Developer of photodynamic therapy systems for solid tumors

spectracure.com

Headquarters: Sweden
Founded year: 2003
Company type: Public company
Number of employees: 20–50

Last updated Today

Latest news about SpectraCure

In short: SpectraCure appointed Fata Mrsic as CFO, reported a Q1 2026 loss of -6.1 MSEK, and achieved positive clinical results for its prostate cancer study.

Company announcements

June 12 SpectraCure

SpectraCure has decided on a rights issue of approximately SEK 34.2 million

The issue aims to finance clinical studies and prepare for phase 3.

May 27 SpectraCure

SpectraCure held its annual general meeting on May 27, 2026

The annual general meeting adopted the income statement, granted discharge from liability, re-elected the board, decided on no dividend, authorization for share issue, and guidelines for remuneration.

May 27 SpectraCure

SpectraCure publishes quarterly report for the first quarter of 2026

Other operating income amounted to 310 TSEK and profit after tax to -6 139 TSEK. Cash flow from operating activities was -4 778 TSEK.

May 5 SpectraCure

SpectraCure publishes annual report for 2025

The auditor questions the value of assets due to liquidity shortage, but the board assesses that financing can be secured. The annual report is available on the website.

Media coverage

May 27 Dagens industri

Spectracure reduces the loss slightly

The medical technology company Spectracure, listed on the Nasdaq First North trading platform, reports a net result of -6.1 million kronor for the...

12 February 2024 Nyheter24

Spectracure applies for permission for clinical study of primary prostate cancer

The research company Spectracure has decided to apply for permission to initiate a clinical study for primary localized prostate cancer. This appears from a press release.The board and management have during...

12 February 2022 Life Science Sweden

Spectracure receives EU grant to develop its treatment for prostate cancer

With an EU grant of 125,000 euros, equivalent to 1.3 million Swedish kronor, Spectracure will adapt its system for the treatment of prostate cancer, in order to be able to mass-produce...

12 February 2020 Reuters

Spectracure FDA Has Approved Co's New Protocol For Clinical Trials

China's Alibaba , said on Friday artificial intelligence was key to expanding its cloud computing business, as it reported strong quarterly growth in the sector...

Never miss news about SpectraCure

Track SpectraCure and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.